SCHEMBL8577334

SCHEMBL8577334

C/C=C\N1C(=O)c2ccccc2C1=O

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 1/20 0.43
CYP1A2 P05177 1/20 0.42
POLB P06746 1/20 0.40
RPS6KA2 Q15349 1/20 0.39
ALDH1A1 P00352 3/20 0.39
MAPT P10636 1/20 0.39
CA12 O43570 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
TTR P02766 1/20 0.38
CES1 P23141 1/20 0.38
EHMT2 Q96KQ7 1/20 0.38
EHMT1 Q9H9B1 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
NR1H2 P55055 1/20 0.37
NR1H3 Q13133 1/20 0.37
SCN2A Q99250 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31377013 1.00 CASP3 (0.43) CASP3CYP1A2POLBRPS6KA2ALDH1A1
SCHEMBL8577340 1.00 CASP3 (0.43) CASP3CYP1A2POLBRPS6KA2ALDH1A1
SCHEMBL19533850 1.00 CASP3 (0.43) CASP3CYP1A2POLBRPS6KA2ALDH1A1
SCHEMBL30559874 1.00 CASP3 (0.43) CASP3CYP1A2POLBRPS6KA2ALDH1A1
SCHEMBL1553885 0.81 CASP3 (0.46) CASP3CYP1A2POLBALDH1A1CA12
SCHEMBL19533849 0.77 CYP1A2 (0.42) CASP3CYP1A2POLBRPS6KA2ALDH1A1
SCHEMBL28669956 0.77 DRD3 (0.41) CASP3CYP1A2RPS6KA2ALDH1A1MAPT
SCHEMBL10658088 0.77 ALDH1A1 (0.51) POLBRPS6KA2ALDH1A1MAPTMEN1
SCHEMBL10658092 0.77 ALDH1A1 (0.51) POLBRPS6KA2ALDH1A1MAPTMEN1
SCHEMBL20954062 0.75 POLB (0.46) CASP3CYP1A2POLBALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170226111-A1 MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS JANSSEN SCIENCES IRELAND UC (IE) 2017-08-10 US disclosed
WO-1998018833-A1 POLY(VINYL AMINE) ANALOGS UNIVERSITY OF MASSACHUSETTS (US) 1998-05-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170226111-A1 MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS CYP2A7, CYP3A7, HCCS CASP3 2622/4885CYP1A2 41/4885POLB 2176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.